Example: stock market
Injection site reactions - NCIRS
any vaccine but are more common after booster doses of diphtheria, tetanus and pertussis (DTPa/dTpa). The inflammatory changes develop over a few hours following vaccination, peak at 24 to 48 hours and resolve completely within a week. Decreased range of limb movement is uncommon, and the individual is systemically well. ...
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Pertussis vaccines for Australians - NCIRS fact sheet
ncirs.org.auand 2012. In 2011, 38,732 notified cases were reported nationally . The highest rates of disease were in infants <6 months of age and children 5–9 years of age. Who should be vaccinated • In Australia, pertussis vaccine is available on the National Immunisation Program (NIP) for children at 2, 4, 6, 18 months and 4 years of age.
![[Type text] Meningococcal vaccines - NCIRS](/cache/preview/0/e/3/6/6/1/8/a/thumb-0e36618a7370d9cfa86ed8d2bb37b564.jpg)
[Type text] Meningococcal vaccines - NCIRS
ncirs.org.auMeningococcal disease is a rare but serious infection caused by the bacterium . Neisseria meningitidis (N. meningitidis). There are 13 serogroups. ... polysaccharides of the organism’s outer membrane capsule. Globally, most cases of meningococcal disease are caused by serogroups A, B, C, W and Y.
Meningococcal vaccines for Australians - NCIRS
ncirs.org.auMeningococcal vaccines for Australians | 1 July 2020 Fact sheet 3 . The disease . Meningococcal disease is a relatively rare but serious infection caused by the bacterium . Neisseria meningitidis, commonly known as the meningococcus. There are 13 serogroups, distinguished by differences in the surface polysaccharides of the organism’s outer ...
Immunisation recommendations for children in Australia
ncirs.org.auFor further details, refer to The Australian Immunisation Handbook. l MenACWY vaccine is recommended for all people ≥6 weeks of age who wish to reduce the likelihood of becoming ill with meningococcal disease, and is strongly recommended for infants and children aged <2 years and adolescents aged 15–19 years.
Related documents
NSW School Vaccination Program Year 7
www.health.nsw.gov.auA combination diphtheria-tetanus-whooping cough vaccine (dTpa) will be offered as a single dose to provide protection against diphtheria, tetanus and whooping cough. This booster dose is essential for maintaining immunity into adulthood after the previous diphtheria-tetanus-whooping cough vaccines given in childhood.